Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.20
- Piotroski Score 2.00
- Grade Buy
- Symbol (TOI)
- Company The Oncology Institute, Inc.
- Price $0.15
- Changes Percentage (-0.64%)
- Change -$0
- Day Low $0.15
- Day High $0.17
- Year High $2.50
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $8.00
- High Stock Price Target $10.00
- Low Stock Price Target $6.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.81
- Trailing P/E Ratio -0.56
- Forward P/E Ratio -0.56
- P/E Growth -0.56
- Net Income $-83,068,000
Income Statement
Quarterly
Annual
Latest News of TOI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Brondell Swash 1400 review: An expensive, but luxurious bidet toilet seat with a ton of features
Business Insider may earn commissions from our links. Bidets offer superior hygiene compared to dry toilet paper. The Brondell Swash 1400 bidet provides customizable features such as adjustable water ...
By Business Insider | 3 days ago -
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Bristol Myers Squibb shared promising data on CC-97540, a new CAR T Cell Therapy for autoimmune diseases, at ACR 2024. Manufactured using NEX-TTM process, it showed positive safety and efficacy result...
By Yahoo! Finance | 4 days ago -
Meet the Americans stocking up on cars, skincare, and toilet paper ahead of Trump's potential trade restrictions
After Trump's election victory, individuals like Marissa Garcia and business owners began stocking up on goods fearing price increases due to proposed tariffs. They anticipate financial strains and ar...
By Business Insider | 6 days ago
